Across TCGA pan-cancer cohorts, MIR520D RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR520D data layer compared with 1 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR520D RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR520D expression acts as an unfavorable survival marker, although some lineages such as STAD and SKCM show a favorable association.

STAD, KIRC, and TGCT are the cancer types where MIR520D RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	1.000	0.309	.034	18	view →
KIRC	OS	Tertile	All	0.630	0.818	.008	18	view →
TGCT	DFS	Tertile	All	0.125	0.807	<.001	18	view →
SKCM	DFS	Tertile	II,III,IV	1.000	0.249	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR520D tumor-vs-normal RNA expression · all MIR520D data types